We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pharmaceutical Testing and Analytical Services Market

Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others; and End User: Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Analytical Services Support Development of Small-molecule COVID-19 Drugs

The coronavirus (COVID-19) outbreak has put immense pressure on the life sciences industry to innovate in vaccines and treatments. Hence, the RSSL Group has stepped in to offer analytical support services to pharmaceutical companies. Currently, there is an unprecedented demand for technical support pertaining to raw material and finished product testing. Hence, companies in the pharmaceutical testing and analytical services market are meeting demands pertaining to the development of small-molecule drugs and vaccines.

Apart from drugs, companies in the pharmaceutical testing and analytical services market have joined the race to innovate in disinfectants and medical devices that help in combating coronavirus. There is a growing demand for an agile approach and rapid response in the realm of COVID-19 medical treatments. Companies are establishing multi-disciplinary groups that are working on accelerated deadlines. These groups comprise of specialists that conduct contamination identification.

Request a sample to get extensive insights into the Pharmaceutical Testing and Analytical Services Market

Australian Companies Seek Queues from NMI in Low-level Active Ingredients Measurement

Apart from growth opportunities in North America, companies in the pharmaceutical testing and analytical services market are unlocking business avenues in Australia. As such, the National Measurement Institute (NMI) dictates analytical services for Australian manufacturers. Companies in the Australia pharmaceutical testing and analytical services market are boosting their credibility by complying with the regulations laid down by the NMI. As such, the Australia Government is investing in state-of-the-art laboratories that carry out low-level active ingredients measurement and testing of organic residues in medicines.
Companies are gaining efficacy in specialized testing for product verification validation and medicinal cannabis. They are increasing their services to provide consultation to clients that are facing problems in chemical analysis. There is a demand for professional and impartial measurement services. After the coronavirus outbreak, companies are acquiring proficiency in crisis response testing.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Companies Expand Portfolio in Release Testing of Innovative Products and Microbiology

The pharmaceutical testing and analytical services market is projected to reach the value of US$ 10.7 Bn by the end of 2030. This is evident since the U.S. employers spend billions of dollars in pre-employment drug testing. However, it has been discovered that urine and blood testing for cannabis use are ineffective in revealing intoxication. Hence, companies in the pharmaceutical testing and analytical services market are becoming aware about cognitive impairment testing to generate accurate outcomes about cannabis intoxication.

There is a growing demand for pharmaceutical testing and analytical services with regard to biological and chemical substances. Solvias— a specialist in contract services for pharmaceutical, biotech, and medical device companies, is expanding its portfolio in elemental and trace analysis, microbiology, and release testing of innovative products. Companies are building a solid reputation with pharmaceutical companies to conduct analysis of biosimilars, monoclonal antibodies, and therapeutic proteins.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Pharmaceutical Testing and Analytical Services Market
Analyst’s Viewpoint

Companies in the pharmaceutical testing and analytical services market are providing comprehensive analytical support to clients for COVID-19 vaccine excipient and buffer solution testing. The market is estimated to expand at a favorable CAGR of ~11% during the forecast period. However, issues such as recurring manufacturing difficulties and continual process optimization are posing challenges for companies. Thus, service providers should participate in discussions initiated by the FDA, which address concerns regarding new modes of operation. Companies should collaborate with government institutes to conduct industry-led research and build strategic programs for the well-being of public. Moreover, certifications and accreditations help in boosting the service providers’ credibility credentials.

Pharmaceutical Testing and Analytical Services Market: Overview

  • Pharmaceutical testing and quality assurance are important in the pharmaceutical industry. Testing and analysis are carried out, as people’s lives are dependent on the quality and quantity measure of a given medicine.
  • Pharmaceutical testing and analytical services include bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The analytical method used for the analysis of biotechnological or biological products is known as bioanalytical testing. Bioanalytical tests are utilized in drug discovery, drug development, and in the commercialization of drugs.
  • The global pharmaceutical testing and analytical services market has expanded significantly in the last decade due to rise in the number of clinical trials and increase in R&D spending
  • Rise in the number of clinical trials is a major factor boosting the market. The number of clinical trials being conducted globally has been increasing significantly for the past few years. Rise in the number of clinical trials is being driven by a surge in the demand for innovative solutions in the healthcare industry, owing to technological advancements in the industry. For instance, in 2018, 293,341 active clinical trials were carried out for the design and development of new products.
  • Rise in R&D spending and increased focus of biopharmaceutical companies on boosting revenues have propelled the pharmaceutical testing and analytical services market. Drug research and development costs are significantly high. These costs have been increasing consistently over the past few years. Cost of manufacturing a new molecule entity (NME) was estimated to have ranged between US$ 2 Bn to US$ 3.5 Bn in 2019. Furthermore, total research and development spending is anticipated to increase at a rate of over 2% to 3% by 2020, primarily driven by significant unmet needs and strong technological advances.
  • The analytical testing industry has been witnessing a high volume of acquisitions over the past few years. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market.
  • These factors are projected to drive the pharmaceutical testing and analytical services market during the forecast period

Market Segmentation: Pharmaceutical Testing and Analytical Services Market

  • Based on service type, the global pharmaceutical testing and analytical services market has been divided into type bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further divided into cell-based assays, virology testing, and others.
  • The method development & validation segment has been further sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. Raw material testing includes heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others.
  • The bioanalytical testing segment is likely to dominate the global pharmaceutical testing and analytical services market during the forecast period
  • In terms of end-user, the global pharmaceutical testing and analytical services market has been categorized into medical device companies, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical companies segment dominated the global pharmaceutical testing and analytical services market, in terms of revenue, in 2019.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Pharmaceutical Testing and Analytical Services Market

  • In terms of region, the global pharmaceutical testing and analytical services market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market value (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the global pharmaceutical testing and analytical services market, which would help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Pharmaceutical Testing and Analytical Services Market: Major Players

  • The pharmaceutical testing and analytical services market report concludes with the company profiles section, which includes key information about major players in the global pharmaceutical testing and analytical services market
  • Leading players analyzed in the pharmaceutical testing and analytical services market report include
    • Eurofins Scientific,
    • Laboratory Corporation of America Holdings,
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.,
    • SGS S.A.,
    • Intertek Group plc,
    • RD Laboratories, Inc.,
    • WuXi AppTec Co., Ltd.,
    • DYNALABS LLC (Infinity Laboratories),
    •  ARL Bio Pharma
  • Each of these players has been profiled in the pharmaceutical testing and analytical services market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Pharmaceutical Testing and Analytical Services Market – Segmentation

TMR’s study on the global pharmaceutical testing and analytical services market includes information divided into three segments: service type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global pharmaceutical testing and analytical services market are discussed in detail.

Service Type

  • Bioanalytical Testing
    • Cell-based Assays
    • Virology Testing
    • Others
  • Method Development & Validation
    • Extractables & Leachables Method Development and Validation
    • Stability-indicating Method ValidationProcess Impurity Method Development & Validation
    • Others
  • Raw Material Testing
    • Heavy Metal Testing
    • Complete Compendial Testing
    • Others
  • Stability Testing
    • Drug Substance Stability Testing
    • Formulation Evaluation Stability Testing
    • Others
  • Microbial Testing
    • Microbial Limit Testing
    • Sterility Testing
    • Endotoxin Testing
    • Others
  • Others

End User

  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of pharmaceutical testing and analytical services market?

Pharmaceutical testing and analytical services market to reach valuation of US$ 10.7 Bn by 2030

What is the anticipated CAGR of the pharmaceutical testing and analytical services market in the forecast period?

Pharmaceutical testing and analytical services market is projected to expand at a CAGR of ~11% from 2020 to 2030

What are the key driving factors for the growth of the pharmaceutical testing and analytical services market?

Pharmaceutical testing and analytical services market is driven by increase in the number of clinical trials and rising prevalence of cancer

Which region is expected to project the highest market share in the global pharmaceutical testing and analytical services market?

North America dominated the global pharmaceutical testing and analytical services market and this trend is anticipated to continue during the forecast period

Who are the key players in the global pharmaceutical testing and analytical services market?

Key players in the global pharmaceutical testing and analytical services market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast

    4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook

5. Market Outlook

    5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

    5.2. Clinical Trials Analysis

    5.3. Covid-19 Impact Analysis

6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

    6.1. Introduction

    6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        6.3.1. Bioanalytical Testing

            6.3.1.1. Cell-Based Assays

            6.3.1.2. Virology Testing

            6.3.1.3. Others

        6.3.2. Method Development & Validation

            6.3.2.1. Extractables & Leachables Method Development & Validation

            6.3.2.2. Stability-indicating Method Validation

            6.3.2.3. Process Impurity Method Development & Validation

            6.3.2.4. Others

        6.3.3. Raw Material Testing

            6.3.3.1. Heavy Metal Testing

            6.3.3.2. Complete Compendial Testing

            6.3.3.3. Others

        6.3.4. Stability Testing

            6.3.4.1. Drug Substance Stability Testing

            6.3.4.2. Formulation Evaluation Stability Testing

            6.3.4.3. Others

        6.3.5. Microbial Testing

            6.3.5.1. Microbial Limit Testing

            6.3.5.2. Sterility Testing

            6.3.5.3. Endotoxin Testing

            6.3.5.4. Others

        6.3.6. Others

    6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        7.3.1. Medical Device Companies

        7.3.2. Pharmaceutical & Biopharmaceutical Companies

        7.3.3. Others

    7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region

    8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region

    8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region

    8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

9. North America Pharmaceutical Testing and Analytical Services Market Analysis

    9.1. North America Pharmaceutical Testing and Analytical Services Market Overview

    9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country

    9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country

        9.3.1. U.S.

        9.3.2. Canada

    9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        9.5.1. Bioanalytical Testing

            9.5.1.1. Cell-Based Assays

            9.5.1.2. Virology Testing

            9.5.1.3. Others

        9.5.2. Method Development & Validation

            9.5.2.1. Extractables & Leachables Method Development & Validation

            9.5.2.2. Stability-indicating Method Validation

            9.5.2.3. Process Impurity Method Development & Validation

            9.5.2.4. Others

        9.5.3. Raw Material Testing

            9.5.3.1. Heavy Metal Testing

            9.5.3.2. Complete Compendial Testing

            9.5.3.3. Others

        9.5.4. Stability Testing

            9.5.4.1. Drug Substance Stability Testing

            9.5.4.2. Formulation Evaluation Stability Testing

            9.5.4.3. Others

        9.5.5. Microbial Testing

            9.5.5.1. Microbial Limit Testing

            9.5.5.2. Sterility Testing

            9.5.5.3. Endotoxin Testing

            9.5.5.4. Others

        9.5.6. Others

    9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        9.7.1. Medical Devices Companies

        9.7.2. Pharmaceutical & Biopharmaceutical Companies

        9.7.3. Others

10. Europe Pharmaceutical Testing and Analytical Services Market Analysis

    10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview

    10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        10.3.1. Germany

        10.3.2. France

        10.3.3. U.K.

        10.3.4. Italy

        10.3.5. Spain

        10.3.6. Rest of Europe

    10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        10.5.1. Bioanalytical Testing

            10.5.1.1. Cell-Based Assays

            10.5.1.2. Virology Testing

            10.5.1.3. Others

        10.5.2. Method Development & Validation

            10.5.2.1. Extractables & Leachables Method Development & Validation

            10.5.2.2. Stability-indicating Method Validation

            10.5.2.3. Process Impurity Method Development & Validation

            10.5.2.4. Others

        10.5.3. Raw Material Testing

            10.5.3.1. Heavy Metal Testing

            10.5.3.2. Complete Compendial Testing

            10.5.3.3. Others

        10.5.4. Stability Testing

            10.5.4.1. Drug Substance Stability Testing

            10.5.4.2. Formulation Evaluation Stability Testing

            10.5.4.3. Others

        10.5.5. Microbial Testing

            10.5.5.1. Microbial Limit Testing

            10.5.5.2. Sterility Testing

            10.5.5.3. Endotoxin Testing

            10.5.5.4. Others

        10.5.6. Others

    10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        10.7.1. Medical Devices Companies

        10.7.2. Pharmaceutical & Biopharmaceutical Companies

        10.7.3. Others

11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis

    11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview

    11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        11.3.1. Japan

        11.3.2. China

        11.3.3. India

        11.3.4. Australia & New Zealand

        11.3.5. Rest of Asia Pacific

    11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        11.5.1. Bioanalytical Testing

            11.5.1.1. Cell-Based Assays

            11.5.1.2. Virology Testing

            11.5.1.3. Others

        11.5.2. Method Development & Validation

            11.5.2.1. Extractables & Leachables Method Development & Validation

            11.5.2.2. Stability-indicating Method Validation

            11.5.2.3. Process Impurity Method Development & Validation

            11.5.2.4. Others

        11.5.3. Raw Material Testing

            11.5.3.1. Heavy Metal Testing

            11.5.3.2. Complete Compendial Testing

            11.5.3.3. Others

        11.5.4. Stability Testing

            11.5.4.1. Drug Substance Stability Testing

            11.5.4.2. Formulation Evaluation Stability Testing

            11.5.4.3. Others

        11.5.5. Microbial Testing

            11.5.5.1. Microbial Limit Testing

            11.5.5.2. Sterility Testing

            11.5.5.3. Endotoxin Testing

            11.5.5.4. Others

        11.5.6. Others

    11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        11.7.1. Medical Devices Companies

        11.7.2. Pharmaceutical & Biopharmaceutical Companies

        11.7.3. Others

12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis

    12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview

    12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        12.3.1. Brazil

        12.3.2. Mexico

        12.3.3. Rest of Latin America

    12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        12.5.1. Bioanalytical Testing

            12.5.1.1. Cell-Based Assays

            12.5.1.2. Virology Testing

            12.5.1.3. Others

        12.5.2. Method Development & Validation

            12.5.2.1. Extractables & Leachables Method Development & Validation

            12.5.2.2. Stability-indicating Method Validation

            12.5.2.3. Process Impurity Method Development & Validation

            12.5.2.4. Others

        12.5.3. Raw Material Testing

            12.5.3.1. Heavy Metal Testing

            12.5.3.2. Complete Compendial Testing

            12.5.3.3. Others

        12.5.4. Stability Testing

            12.5.4.1. Drug Substance Stability Testing

            12.5.4.2. Formulation Evaluation Stability Testing

            12.5.4.3. Others

        12.5.5. Microbial Testing

            12.5.5.1. Microbial Limit Testing

            12.5.5.2. Sterility Testing

            12.5.5.3. Endotoxin Testing

            12.5.5.4. Others

        12.5.6. Others

    12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        12.7.1. Medical Devices Companies

        12.7.2. Pharmaceutical & Biopharmaceutical Companies

        12.7.3. Others

13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis

    13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview

    13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        13.3.1. GCC Countries

        13.3.2. South Africa

        13.3.3. Rest of Middle East & Africa

    13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        13.5.1. Bioanalytical Testing

            13.5.1.1. Cell-Based Assays

            13.5.1.2. Virology Testing

            13.5.1.3. Others

        13.5.2. Method Development & Validation

            13.5.2.1. Extractables & Leachables Method Development & Validation

            13.5.2.2. Stability-indicating Method Validation

            13.5.2.3. Process Impurity Method Development & Validation

            13.5.2.4. Others

        13.5.3. Raw Material Testing

            13.5.3.1. Heavy Metal Testing

            13.5.3.2. Complete Compendial Testing

            13.5.3.3. Others

        13.5.4. Stability Testing

            13.5.4.1. Drug Substance Stability Testing

            13.5.4.2. Formulation Evaluation Stability Testing

            13.5.4.3. Others

        13.5.5. Microbial Testing

            13.5.5.1. Microbial Limit Testing

            13.5.5.2. Sterility Testing

            13.5.5.3. Endotoxin Testing

            13.5.5.4. Others

        13.5.6. Others

    13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        13.7.1. Medical Devices Companies

        13.7.2. Pharmaceutical & Biopharmaceutical Companies

        13.7.3. Others

14. Competitive Landscape

    14.1. Competition Matrix

    14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company

    14.3. Company Profile

        14.3.1. Eurofins Scientific  

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Laboratory Corporation of America Holdings

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. SGS S.A

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Intertek Group plc

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. RD Laboratories, Inc

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. WuXi AppTec Co., Ltd.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. DYNALABS LLC (Infinity Laboratories)

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. ARL Bio Pharma

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

List of Tables

Table 01: Epidemiology of COVID-19 Country/Sub-region

Table 02: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 03: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 04: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 05: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 06: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 08: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 10: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 11: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 12: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 13: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 15: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 16: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 17: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 18: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 19: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 20: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 22: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 23: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 24: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 25: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 27: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 34: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 36: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 37: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 38: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 39: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 40: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 41: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 49: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Service Type (2019)

Figure 03: Global Pharmaceutical Testing and Analytical Services Market Value Share, by End-user (2019

Figure 04: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Region (2019)

Figure 05: Number of Registered Studies, by Location

Figure 06: Number of Registered Studies, by Intervention

Figure 07: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 08: Global Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Bioanalytical Testing, 2018–2030

Figure 10: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Method Development & Validation, 2018–2030

Figure 11: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Raw Material Testing, 2018–2030

Figure 12: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Stability Testing, 2018–2030

Figure 13: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Microbial Testing, 2018–2030

Figure 14: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Others, 2018–2030

Figure 15: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 16: Global Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 17: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Medical Device Companies, 2018–2030

Figure 18: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Pharmaceutical & Biopharmaceutical Companies, 2018–2030

Figure 19: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Others, 2018–2030

Figure 20: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Region, 2019 and 2030

Figure 21: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Region

Figure 22: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 23: North America Pharmaceutical Testing and Analytical Services Market Value Share (%), by Country, 2019 and 2030

Figure 24: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Country, 2020–2030

Figure 25: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 26: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 27: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 28: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 29: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 30: Europe Pharmaceutical Testing and Analytical Services Market Value Share (%), by Country, 2019 and 2030

Figure 31: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by Country, 2020–2030

Figure 32: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 33: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 34: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 35: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 36: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 37: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 38: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030

Figure 39: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 40: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 41: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 42: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 43: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 44: Latin America Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 45: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030

Figure 46: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 47: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 48: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 49: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 50: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 51: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 52: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030

Figure 53: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 54: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030

Figure 55: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030

Figure 56: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030

Figure 57: Global Pharmaceutical Testing and Analytical Services Market Share, by Company, 2019

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved